We looked up the literature and found that most of the components were down-regulated to MAPK8, but the overall results were beneficial to our conclusion because the mRNA expression of RELA, STAT3, and TGFB1 increased significantly in AD, and our CR or chemical constituents had a down-regulating effect on them. This evidence concerns the gene RELA and Alzheimer disease.